Teva Settles Patent Litigation with Pfizer on Celebrex; Has Received Tenative FDA Approval for All Strengths; May Start Generic Versions in December
April 17, 2014 at 08:39 AM EDT
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that its subsidiary Teva Pharmaceuticals USA, Inc. has entered into a ...
